Android app on Google Play

Vanda Pharmaceuticals (VNDA) Misses Q4 EPS by 1c

February 12, 2013 7:31 AM EST Send to a Friend
Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) reported Q4 EPS of ($0.23), $0.01 worse than the analyst estimate of ($0.22). Revenue for the quarter came in at $7.9 million versus the consensus estimate of $8.6 million.

For earnings history and earnings-related data on Vanda Pharmaceuticals, Inc. (VNDA) click here.




You May Also Be Interested In


Related Categories

Earnings

Related Entities

Earnings

Add Your Comment